Renovaro logo

Renovaro Share Price (NASDAQ: RENB)

$0.23

Live

Last updated on

Check the interactive Renovaro Stock chart to analyse performance

Renovaro stock performance

as on August 22, 2025 at 12:38 AM IST

  • Today's Low:$0.23
    Today's High:$0.23

    Day's Volatility :3.14%

  • 52 Weeks Low:$0.22
    52 Weeks High:$2.10

    52 Weeks Volatility :89.52%

Renovaro Stock Returns

PeriodRenovaro IncIndex (Russel 2000)
3 Months
-30.98%
0.0%
6 Months
-72.83%
0.0%
1 Year
-64.59%
0.0%
3 Years
-90.25%
-9.6%

Renovaro Inc Key Stats

Check Renovaro key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.23
Open
$0.23
Today's High
$0.2324
Today's Low
$0.225
Market Capitalization
$54.1M
Today's Volume
$450.7K
52 Week High
$2.1
52 Week Low
$0.2201
Revenue TTM
$0.0
EBITDA
$-19.8M
Earnings Per Share (EPS)
$-0.25
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-53.17%

Stock Returns calculator for Renovaro Stock including INR - Dollar returns

The Renovaro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Renovaro investment value today

Current value as on today

₹39,312

Returns

₹60,688

(-60.69%)

Returns from Renovaro Stock

₹64,615 (-64.62%)

Dollar Returns*

₹3,927 (+3.93%)

Indian investors sentiment towards Renovaro Stock

-12%

Period: Jul 21, 2025 to Aug 20, 2025. Change in 30 Days versus previous period

Search interest for Renovaro Stock from India on INDmoney has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Renovaro Inc

  • Name

    Holdings %

  • BlackRock Inc

    3.19%

  • Vanguard Group Inc

    2.13%

  • Geode Capital Management, LLC

    1.03%

  • State Street Corp

    0.87%

  • Northern Trust Corp

    0.36%

  • UBS Group AG

    0.30%

Analyst Recommendation on Renovaro Stock

Rating
Trend

Renovaro Stock Insights

  • Price Movement

    In the last 1 month, RENB stock has moved down by -25.3%
  • RENB vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.1% return, outperforming this stock by 128.7%
  • RENB vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.1% return, outperforming this stock by 202.5%

Renovaro Technicals Summary

Sell

Neutral

Buy

Renovaro is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Renovaro Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Renovaro Inc logo
-25.34%
-72.83%
-64.59%
-90.25%
-94.19%
Regeneron Pharmaceuticals, Inc. logo
5.39%
-15.07%
-50.13%
-3.42%
-0.61%
Beone Medicines Ltd logo
4.61%
26.63%
56.19%
78.75%
30.26%
Vertex Pharmaceuticals Incorporated logo
-16.11%
-17.89%
-18.87%
34.22%
47.47%
Alnylam Pharmaceuticals, Inc. logo
40.82%
82.49%
64.08%
110.21%
247.67%

About Renovaro Inc

Renovaro Inc., a pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands. It operates through two segments, RENB and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company has a strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The company was formerly known as Renovaro Biosciences Inc. and changed its name to Renovaro Inc. in February 2024. Renovaro Inc. is headquartered in Los Angeles, California.
Organization
Renovaro
Employees
25
CEO
Mr. David H. Weinstein
Industry
Miscellaneous

Key Management of Renovaro Inc

NameTitle
Mr. David H. Weinstein
CEO & Director
Mr. Nathen Fuentes CPA
Chief Financial Officer
Mr. Greg Duczynski Ph.D.
Senior Vice President for Clinical Operations

Important FAQs about investing in RENB Stock from India :

What is Renovaro share price today?

Renovaro share price today is $0.23 as on . Renovaro share today touched a day high of $0.23 and a low of $0.23.

What is the 52 week high and 52 week low for Renovaro share?

Renovaro share touched a 52 week high of $2.10 and a 52 week low of $0.22. Renovaro stock price today i.e. is trending at $0.23, lower by 89.05% versus the 52 week high.

How to invest in Renovaro Stock (RENB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Renovaro on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Renovaro Shares that will get you 6.5217 shares as per Renovaro share price of $0.23 per share as on August 22, 2025 at 12:38 AM IST.

What is the minimum amount required to buy Renovaro Stock (RENB) from India?

Indian investors can start investing in Renovaro (RENB) shares with as little as ₹87.2 or $1 (as of August 21, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹872.00 in Renovaro stock (as per the Rupee-Dollar exchange rate as on August 21, 2025). Based on Renovaro share’s latest price of $0.23 as on August 22, 2025 at 12:38 AM IST, you will get 43.4783 shares of Renovaro. Learn more about fractional shares .

What are the returns that Renovaro has given to Indian investors in the last 5 years?

Renovaro stock has given -94.19% share price returns and 17.57% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?